We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Don’t drink and pink

19 August 2015 By Robert Cyran

U.S. regulators approved the first pill for increasing sexual desire in women. The drug had been rejected twice because it’s barely effective and carries severe adverse effects. The lesson for pharma firms: a public relations campaign successfully changed a watchdog’s mind.  

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)